ESC Premium Access

Immuno-inflammation as therapeutic target in heart failure

Event: ESC CONGRESS 2019
Topic: Basic Science
Session type: Abstract Sessions
Date: 1 September 2019
Time: 16:40 - 17:50

Congress Session

5 presentations in this session

PD1-blocking immune checkpoint inhibitor therapy for malignant melanoma induces left ventricular dysfunction

Speaker: Doctor L. Michel (Essen, DE)

Elevated interleukin-6 and interleukin-18 concentrations predict residual inflammatory risk both before and after interleukin-1beta inhibition with canakinumab

Speaker: Professor P. Ridker (Boston, US)

Th17 signature, autoimmunity and differentially expressed genes in cardiomyopathy and heart failure

Speaker: Professor M. Cunningham (Oklahoma City, US)

Reparative macrophage transplantation for myocardial repair: a refinement of bone marrow mononuclear cell-based therapy

Speaker: Mr M. Podaru (London, GB)

Effects of a selective small-molecule formyl peptide receptor 2 agonist on post myocardial inflammation and left ventricular structure-function relationships

Speaker: Doctor R. Garcia (Princeton, US)

5 speakers from this session

Doctor Lars Michel

University of Duisburg-Essen - West-German Heart and Vascular Center, Essen (Germany)
0 follower

Professor Paul M Ridker

Brigham and Women's Hospital, Boston (United States of America)
27 presentations

Professor Madeleine Cunningham

University of Oklahoma Health Sciences Center, Oklahoma City (United States of America)
0 follower

Mr Mihai Nicolae Podaru

St Bartholomew's and Queen Mary University, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

Doctor Ricardo Garcia

Bristol Myers Squibb, Princeton (United States of America)
0 follower

This platform is supported by

logo Novo Nordisk